Empagliflozin protects the heart from atrial fibrillation in rats through inhibiting the NF-κB/HIF-1α regulatory axis and atrial remodeling
Autor: | Badreldin, Hussein, Elshal, Mahmoud, El-Karef, Amr, Ibrahim, Tarek |
---|---|
Zdroj: | In International Immunopharmacology 25 December 2024 143 Part 2 |
Databáze: | ScienceDirect |
Externí odkaz: |